The Day My Gut Feeling Led Me Astray von Noronha, Vanita

Volltext

Making a case for cancer research in India von Vanita Noronha

Volltext

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial von Murthy, Vedang, Maitre, Priyamvada, Kannan, Sadhana, Panigrahi, Gitanjali, Krishnatry, Rahul, Bakshi, Ganesh, Prakash, Gagan, Pal, Mahendra, Menon, Santosh, Phurailatpam, Reena, Mokal, Smruti, Chaurasiya, Dipika, Popat, Palak, Sable, Nilesh, Agarwal, Archi, Rangarajan, Venkatesh, Joshi, Amit, Noronha, Vanita, Prabhash, Kumar, Mahantshetty, Umesh

Volltext

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer von Noronha, Vanita, Patil, Vijay Maruti, Joshi, Amit, Menon, Nandini, Chougule, Anuradha, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Kumar, Rajiv, More, Sucheta, Goud, Supriya, Kadam, Nandkumar, Daware, Nilesh, Bhattacharjee, Atanu, Shah, Srushti, Yadav, Akanksha, Trivedi, Vaishakhi, Behel, Vichitra, Dutt, Amit, Banavali, Shripad Dinanath, Prabhash, Kumar

Volltext

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Me... von Szturz, Petr, Wouters, Kristien, Kiyota, Naomi, Tahara, Makoto, Prabhash, Kumar, Noronha, Vanita, Castro, Ana, Licitra, Lisa, Adelstein, David, Vermorken, Jan B.

Volltext

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial von Noronha, Vanita, Joshi, Amit, Patil, Vijay Maruti, Agarwal, Jaiprakash, Ghosh-Laskar, Sarbani, Budrukkar, Ashwini, Murthy, Vedang, Gupta, Tejpal, D'Cruz, Anil K, Banavali, Shripad, Pai, Prathamesh S, Chaturvedi, Pankaj, Chaukar, Devendra, Pande, Nikhil, Chandrasekharan, Arun, Talreja, Vikas, Vallathol, Dilip Harindran, Mathrudev, Vijayalakshmi, Manjrekar, Aparna, Maske, Kamesh, Bhelekar, Arati Sanjay, Nawale, Kavita, Kannan, Sadhana, Gota, Vikram, Bhattacharjee, Atanu, Kane, Shubhada, Juvekar, Shashikant L, Prabhash, Kumar

Volltext

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer von Patil, Vijay Maruti, Noronha, Vanita, Joshi, Amit, Agarwal, Jaiprakash, Ghosh‐Laskar, Sarbani, Budrukkar, Ashwini, Murthy, Vedang, Gupta, Tejpal, Mahimkar, Manoj, Juvekar, Shashikant, Arya, Supreeta, Mahajan, Abhishek, Agarwal, Archi, Purandare, Nilendu, Rangarajan, Venkatesh, Balaji, Arun, Chaudhari, Sameer Vasant, Banavali, Shripad, Kannan, Sadhana, Bhattacharjee, Atanu, D’Cruz, Anil K., Chaturvedi, Pankaj, Pai, Prathamesh S., Chaukar, Devendra, Pantvaidya, Gouri, Nair, Deepa, Nair, Sudhir, Deshmukh, Anuja, Thiagarajan, Shivakumar, Mathrudev, Vijayalakshmi, Manjrekar, Aparna, Dhumal, Sachin, Maske, Kamesh, Bhelekar, Arti Sanjay, Nawale, Kavita, Chandrasekharan, Arun, Pande, Nikhil, Goel, Alok, Talreja, Vikas, Simha, Vijai, Srinivas, Sujay, Swami, Rohit, Vallathol, Dilip Harindran, Dsouza, Hollis, Shrirangwar, Sameer, Turkar, Siddharth, Abraham, George, Thanky, Aditi Harsh, Patel, Usha, Pandey, Manish Kumar, Prabhash, Kumar

Volltext

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer von Szturz, Petr, Wouters, Kristien, Kiyota, Naomi, Tahara, Makoto, Prabhash, Kumar, Noronha, Vanita, Adelstein, David, Van Gestel, Dirk, Vermorken, Jan B

Volltext

Cancer incidence estimates in adults aged 60 years and older living in low-and-middle-income countries for the years 2020 and 2040 von Pilleron, Sophie, Gnangon, Freddy, Noronha, Vanita, Soto-Perez-De-Celis, Enrique

Volltext

Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab von Patel, Usha, Pandey, Manish, Kannan, Sadhana, Samant, Tanuja A., Gera, Poonam, Mittal, Neha, Rane, Swapnil, Patil, Asawari, Noronha, Vanita, Joshi, Amit, Patil, Vijay M., Prabhash, Kumar, Mahimkar, Manoj B.

Volltext

Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab von Patel, Usha, Kannan, Sadhana, Rane, Swapnil U., Mittal, Neha, Gera, Poonam, Patil, Asawari, Manna, Subhakankha, Shejwal, Vishwayani, Noronha, Vanita, Joshi, Amit, Patil, Vijay M., Prabhash, Kumar, Mahimkar, Manoj B.

Volltext

Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity von Chougule, Anuradha, Prabhash, Kumar, Noronha, Vanita, Joshi, Amit, Thavamani, Abhishek, Chandrani, Pratik, Upadhyay, Pawan, Utture, Sagarika, Desai, Saral, Jambhekar, Nirmala, Dutt, Amit

Volltext

Authors’ reply to Thota and Seshadri von Sehgal, Arshiya, Noronha, Vanita, Prabhash, Kumar

Volltext

Patient advocacy and support groups in India: focus on lung cancer von Noronha, Vanita, Mahajan, Vandana, Prakash, Ravi, Sharma, Sanjeev, Prabhash, Kumar

Volltext

Authors' reply to Maskomani von Shah, Minit, Noronha, Vanita, Prabhash, Kumar

Volltext

Authors' reply to Saleem et al von Sabu, Tabitha, Noronha, Vanita, Prabhash, Kumar

Volltext

Authors' reply to Bhattacharya von Kumar, Srigadha, Noronha, Vanita, Prabhash, Kumar

Volltext

Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs von Butle, Ashwin, Joshi, Asim, Noronha, Vanita, Prabhash, Kumar, Dutt, Amit

Volltext

Authors' reply to Bhargav and Mayilvaganan von Saha, Saswata, Noronha, Vanita, Prabhash, Kumar

Volltext

Editorial: Site specific imaging guidelines in head & neck, and skull base cancers von Vaish, Richa, Mahajan, Abhishek, Ghosh Laskar, Sarbani, Prabhash, Kumar, Noronha, Vanita, D'Cruz, Anil K

Volltext